All investment decisions must be based on and rationalized by public health needs of low resource countries.
We recognize the importance of delivering tangible results from investments into a positive impact on the lives of patients. The anticipated level of impact and potential for success are key criteria in the selection process for all projects.
We acknowledge that Korean industry and academics have established unique strengths and expertise in life sciences R&D. Our investments seek to help these organizations progress and de-risk the development of those products for public health.
Maintaining transparency in our proposal selection process is key to building and maintaining the credibility of our investments.
Equity is a core value of our business. Our mission is to reduce disparity in basic health care world-wide.